Hospital Centralized Monitoring of Post-market Clinical Safety of Guipi Mixture
Phase 4
- Conditions
- Sleep DisordersG47.900
- Registration Number
- ITMCTR2024000037
- Lead Sponsor
- Anning First People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Patients who meet the indications in the instructions of Guipi Mixture or according to the patient's condition, the clinician judges that the application of Guipi mixture is suitable, and the doctor has issued a prescription for it;
2. Patients who voluntarily participate and sign informed consent;
3. Willing to cooperate with at least one follow-up visit.
Exclusion Criteria
Patients judged by the investigator to be unable to complete or unfit to participate in the study.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Adverse drug events/ Adverse drug reactions;
- Secondary Outcome Measures
Name Time Method